Sonodynamic therapy doubled the median overall survival to 15.7 months and tripled progression-free survival to 5.5 months in ...

Gliomas are the most common brain tumors, and many start off growing slowly as "low-grade" tumors before inevitably becoming ...

Experts debate the value of the new agent for low-grade gliomas with an IDH1 or IDH2 mutation. Some have hailed the drug a ...

Adding rhIL‑7-hyFc to radiation and temozolomide may improve survival in patients with high-grade glioma who are 65 years of age and older.

The E3F05 trial started in September 2009 and enrolled patients with low-grade gliomas who had not received prior radiation ...

BIRMINGHAM, AL, USA I 4, 2024 I Treovir, Inc. announced today the opening of a Phase 2 trial testing G207, an oncolytic HSV immunotherapy, in ...

22 and 47 months for glioblastoma, anaplastic astrocytoma, astrocytoma and oligodendroglioma/mixed group, respectively. Despite a trend toward improvement in survival depending on tumor grade, the ...